Literature DB >> 15900113

Molecular basis of autosomal dominant polycystic kidney disease.

Lulu Al-Bhalal1, Mohammed Akhtar.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a serious, life-threatening genetic disease in which extensive epithelial-lined cysts develop in the kidneys and, to a lesser extent, in other organs such as liver, pancreas, and ovaries. In a majority of cases (80-85%), the gene involved is PKD1, which is located on chromosome 16 (16q13.3) and encodes polycystin-1, a large receptor-like integral membrane protein that contains several extracellular motifs indicative of cell-cell and cell-matrix interaction. In the remaining (10-15%) cases, the disease is milder and is caused by mutational changes in another gene (PKD2), which is located at chromosome 4 (4q21-23) and encodes polcystin-2, a transmembrane protein, which acts as a nonspecific calcium-permeable channel. Both polycystins function together in a nonredundant fashion, through a common pathway, and produce cellular responses that regulate proliferation, migration, differentiation, and kidney morphogenesis. Through combined function of polycystins, normal tubular cells are maintained in a state of terminal differentiation, and their proliferation is strictly controlled. Loss of function of either protein due to gene mutations results in the tubular cells reverting to a less differentiated state, which is more prone to proliferation. Patients with ADPKD carry a germ-line mutation in PKD1 or PKD2. A second somatic mutation in some of the tubular cells results in loss of both normal alleles, leading to loss of polycystin function. The affected cells lose the normal terminally differentiated state, revert to less differentiated phenotype, and undergo proliferation, which leads to cyst formation. As the cysts enlarge over many decades, the normal renal parenchyma is progressively destroyed, leading to renal failure. Recently, the crucial role of primary cilia in modulating proliferation, migration, and differentiation of tubular epithelium has been recognized. Most of the tubular cells have one or two primary cilia projecting from the apical surface into the luminal space. The cilia act as mechanoreceptors as they bend with the urinary flow within the tubules. Both polycystins are strategically located within the cilia and act as important mediators of ciliary mechanosensation. Loss of this important function due to mutational changes in PKD1 or PKD2 leads to loss of normal control over cellular proliferation, resulting in cyst formation. Several other ciliary proteins have recently been found to contribute directly to a wide spectrum of human kidney diseases with cystic phenotype, thus underscoring the pivotal role the primary cilia play in maintaining the normal structure and function of the tubular cells and probably other cells in the body.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900113     DOI: 10.1097/01.pap.0000163959.29032.1f

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  14 in total

1.  Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells.

Authors:  Ni Qiu; Honghao Zhou; Zhousheng Xiao
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

2.  Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease.

Authors:  Murali K Yanda; Boyoung Cha; Cristina V Cebotaru; Liudmila Cebotaru
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

3.  Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.

Authors:  Allison L Brill; Barbara E Ehrlich
Journal:  Cell Signal       Date:  2019-12-02       Impact factor: 4.315

4.  A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.

Authors:  Murali K Yanda; Qiangni Liu; Liudmila Cebotaru
Journal:  J Biol Chem       Date:  2018-06-06       Impact factor: 5.157

5.  Rational proteomics of PKD1. I. Modeling the three dimensional structure and ligand specificity of the C_lectin binding domain of Polycystin-1.

Authors:  Vladimir Pletnev; Robert Huether; Lukas Habegger; Wayne Schultz; William Duax
Journal:  J Mol Model       Date:  2007-04-17       Impact factor: 1.810

6.  Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression.

Authors:  Zhousheng Xiao; Shiqin Zhang; Josh Mahlios; Gan Zhou; Brenda S Magenheimer; Dayong Guo; Sarah L Dallas; Robin Maser; James P Calvet; Lynda Bonewald; Leigh Darryl Quarles
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

7.  Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease.

Authors:  James R Davenport; Amanda J Watts; Venus C Roper; Mandy J Croyle; Thomas van Groen; J Michael Wyss; Tim R Nagy; Robert A Kesterson; Bradley K Yoder
Journal:  Curr Biol       Date:  2007-09-06       Impact factor: 10.834

8.  Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney.

Authors:  Je Yeong Ko; Kyung Hyun Yoo; Seon Ah Song; Do Yeon Kim; Hyun Kyung Kong; Curie Ahn; Han Woong Lee; Duk-Hee Kang; Goo Taeg Oh; Jong Hoon Park
Journal:  J Biol Chem       Date:  2013-01-13       Impact factor: 5.157

9.  Colonic diverticular disease in autosomal dominant polycystic kidney disease: is there really an association? A nationwide analysis.

Authors:  Rodrigo Duarte-Chavez; Jill Stoltzfus; Vikas Yellapu; Noel Martins; Sudip Nanda; Santo Longo; Berhanu Geme; Yecheskel Schneider
Journal:  Int J Colorectal Dis       Date:  2020-09-01       Impact factor: 2.571

10.  Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.

Authors:  Feng Wei; Anil Karihaloo; Vikas P Sukhatme; Zhiheng Yu; Arnaud Marlier; Pankaj Seth; Sekiya Shibazaki; Tong Wang; Stefan Somlo; Lloyd G Cantley
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.